SureTrader Advertisement PRTC
Home > Boards > US Listed > Biotechs > Delcath Systems, Inc. (DCTH)

np Sry8, remember you can pm 4-5 pm

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
toomuchmoney Member Profile
Member Level 
Followed By 211
Posts 15,113
Boards Moderated 0
Alias Born 03/11/01
160x600 placeholder
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 5/4/2016 5:32:53 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/4/2016 5:09:04 PM
Leading U.S. Cancer Centers Join Delcath's Focus Phase 3 Trial For Patients With Hepatic Dominant Ocular Melanoma "PR Newswire (US)" - 5/3/2016 8:00:00 AM
Delcath Announces First CHEMOSAT® Procedures In Turkey "PR Newswire (US)" - 4/8/2016 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 4/7/2016 4:31:52 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/7/2016 4:17:06 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 3/23/2016 4:34:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/23/2016 4:34:03 PM
Delcath Announces 2015 Fourth Quarter and Full Year Financial Results "PR Newswire (US)" - 3/21/2016 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 3/21/2016 6:03:34 AM
Delcath to Present at the 28th Annual ROTH Conference "PR Newswire (US)" - 3/7/2016 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/11/2016 2:54:49 PM
Delcath announces Engagement of Lars E. Birgerson, M.D., Ph. D as global medical consultant "PR Newswire (US)" - 2/11/2016 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 2/10/2016 4:27:11 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/10/2016 4:22:23 PM
Delcath Announces Beginning Of Patient Enrollment In Phase 3 Focus Trial "PR Newswire (US)" - 2/10/2016 8:30:00 AM
Delcath Systems to Present at Upcoming Investor Conferences "PR Newswire (US)" - 2/4/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/22/2016 4:26:04 PM
Delcath Announces Initiation Of Phase 3 Trial Of Melphalan/HDS System For Treatment Of Hepatic Dominant Ocular Melanoma "PR Newswire (US)" - 1/20/2016 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/20/2016 6:03:38 AM
Delcath Announces Special Protocol Assessment Agreement With FDA For New Phase 3 Trial In Hepatic Dominant Ocular Melanoma "PR Newswire (US)" - 1/19/2016 8:00:00 AM
Delcath To Present At NobleCon12 Investor Conference "PR Newswire (US)" - 1/15/2016 10:18:00 AM
Review of Delcath Melphalan/HDS System Published in "Cardiovascular & Interventional Radiology" "PR Newswire (US)" - 1/11/2016 8:30:00 AM
Delcath Prior Phase 3 Trial Results Published In Annals Of Surgical Oncology "PR Newswire (US)" - 12/9/2015 8:59:00 AM
Delcath Announces CHEMOSAT Review Accepted for Publication in Cardiovascular and Interventional Radiology "PR Newswire (US)" - 12/8/2015 8:00:00 AM
toomuchmoney Member Level  Monday, 10/07/13 12:49:02 PM
Re: Sry8 post# 2391
Post # of 3081 
np Sry8, remember you can pm 4-5 pm fridays EST, all good

"charts never lie"
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist